GL1X · GenesisL1 explorer

MolNFT v1 · #106791 · protein

Dual binding mode for 3-(9H-fluoren-9-YLIDENEAMINOOXY)PROPANOIC acid binding to human transthyretin (ttr)

4TQ8: “Dual binding mode for 3-(9H-fluoren-9-YLIDENEAMINOOXY)PROPANOIC acid binding to human transthyretin (ttr)”. X-ray diffraction, 1 ligand (7BD), 3 pockets (best druggability 0.36). MolNFT v1 #106791 on GenesisL1: 3D structure, binding…

PDB
4TQ8
Type
protein
Length
232 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
7BD
Pockets
3 · best druggability 0.36

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 53% strandP02766
BTransthyretinprotein1167% helix, 53% strandP02766

Ligands and binding sites

  • 7BD · 3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1770.360.7716empty
2500.350.7910EDO
3560.280.7513EDO

Interfaces

1 interface between chains.

  • A–B · 949 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 4TQ8 · Dual binding mode for 3-(9H-fluoren-9-ylideneaminooxy)propanoic acid binding to Human… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.